Correlation Between Mangalam Drugs and Par Drugs

Can any of the company-specific risk be diversified away by investing in both Mangalam Drugs and Par Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mangalam Drugs and Par Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mangalam Drugs And and Par Drugs And, you can compare the effects of market volatilities on Mangalam Drugs and Par Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mangalam Drugs with a short position of Par Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mangalam Drugs and Par Drugs.

Diversification Opportunities for Mangalam Drugs and Par Drugs

0.61

Correlation Coefficient

Mangalam Drugs  Par Drugs

Poor diversification

The 3 months correlation between Mangalam and Par is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Mangalam Drugs And and Par Drugs And in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Par Drugs And and Mangalam Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mangalam Drugs And are associated (or correlated) with Par Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Par Drugs And has no effect on the direction of Mangalam Drugs i.e., Mangalam Drugs and Par Drugs go up and down completely randomly.

Pair Corralation between Mangalam Drugs and Par Drugs

Assuming the 90 days trading horizon Mangalam Drugs And is expected to generate 0.52 times more return on investment than Par Drugs. However, Mangalam Drugs And is 1.93 times less risky than Par Drugs. It trades about -0.17 of its potential returns per unit of risk. Par Drugs And is currently generating about -0.39 per unit of risk. If you would invest  12,124  in Mangalam Drugs And on December 1, 2024 and sell it today you would lose (2,932) from holding Mangalam Drugs And or give up 24.18% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Mangalam Drugs And  vs.  Par Drugs And

Mangalam Drugs And

Risk-Adjusted Performance

Very Weak

Over the last 90 days Mangalam Drugs And has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's essential indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Par Drugs And

Risk-Adjusted Performance

Very Weak

Over the last 90 days Par Drugs And has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Mangalam Drugs and Par Drugs

The main advantage of trading using opposite Mangalam Drugs and Par Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mangalam Drugs position performs unexpectedly, Par Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Par Drugs will offset losses from the drop in Par Drugs' long position.

The idea behind Mangalam Drugs And and Par Drugs And pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.